Denali Therapeutics Inc. DNLI Operating margin

Operating margin at other companies

Regeneron PharmaceuticalsREGN

24.7%-2.3pp

Ultragenyx PharmaceuticalRARE

-73.6%-7.3pp

uniQureQURE

-1,071.5%-90.6pp

PTC TherapeuticsPTCT

1.6%-38.7pp

Viridian Therapeutics, Inc.VRDN

-569.7%-284pp

Eton Pharmaceuticals, Inc.ETON

-15.1%—

FAQ

What is Denali Therapeutics Inc.'s operating margin?

Denali Therapeutics Inc. (DNLI) reported operating margin of -37,938% in Q2 2024.

How has Denali Therapeutics Inc.'s operating margin changed year-over-year?

Denali Therapeutics Inc.'s operating margin decreased by 79678.2% year-over-year, from -47.6% to -37,938%.

What is the long-term trend for Denali Therapeutics Inc.'s operating margin?

Over 3 years (2020 to 2023), Denali Therapeutics Inc.'s operating margin has grown at a 47.1% compound annual growth rate (CAGR), from 18.7% to -59.5%.

What does operating margin mean?

Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.